XML 156 R141.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Plans - Summary of Restricted Stock and Stock Option Activity (Detail) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Jan. 31, 2022
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Options, Granted (in shares)   458,881
Options, Exercised (in shares)   (30,355)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Award vesting percentage   50.00%
Reissued treasury stock (in shares)   59,004
Increase in stock compensation expense   $ 18.8
Common Stock    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Options, Granted (in shares)   0
Options, Exercised (in shares)   0
Sterling    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Shares issued (in shares) 87,965,239  
Sterling | Common Stock    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Shares issued (in shares) 1,126,495  
Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Restricted stock, Outstanding at beginning of period (in shares)   529,284
Restricted Stock, Granted (in shares)   711,503
Restricted stock, Sterling replacement awards (in shares)   1,185,499
Restricted stock, Adjustment (in shares)   187,915
Restricted stock, Vested restricted stock awards (in shares)   (993,512)
Restricted stock, Forfeited (in shares)   (140,947)
Restricted stock, Outstanding at end of period (in shares)   1,479,742
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Restricted stock, at beginning of period, Weighted-average Grant Date Fair Value (in dollars per share)   $ 48.77
Restricted stock, Granted (in dollars per share)   54.95
Restricted stock, Sterling replacement awards (in dollars per share)   56.81
Restricted stock, Adjustment (in dollars per share)   56.81
Restricted stock, Vested restricted stock awards (in dollars per share)   48.69
Restricted stock, Forfeited (in dollars per share)   51.43
Restricted stock, at end of period, Weighted-average Grant Date Fair Value (in dollars per share)   $ 50.47
Performance-Based    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Restricted stock, Outstanding at beginning of period (in shares)   266,417
Restricted Stock, Granted (in shares)   307,852
Restricted stock, Sterling replacement awards (in shares)   0
Restricted stock, Adjustment (in shares)   (187,915)
Restricted stock, Vested restricted stock awards (in shares)   (59,400)
Restricted stock, Forfeited (in shares)   (16,580)
Restricted stock, Outstanding at end of period (in shares)   310,374
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Restricted stock, at beginning of period, Weighted-average Grant Date Fair Value (in dollars per share)   $ 50.03
Restricted stock, Granted (in dollars per share)   57.66
Restricted stock, Sterling replacement awards (in dollars per share)   0
Restricted stock, Adjustment (in dollars per share)   47.43
Restricted stock, Vested restricted stock awards (in dollars per share)   56.14
Restricted stock, Forfeited (in dollars per share)   55.63
Restricted stock, at end of period, Weighted-average Grant Date Fair Value (in dollars per share)   $ 57.65
Performance-Based | Minimum    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Award vesting percentage   0.00%
Performance-Based | Maximum    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Award vesting percentage   150.00%
Performance-Based | Share Based Payment Arrangement Executives    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Restricted Stock, Granted (in shares)   127,524
Performance-Based | Sterling | Minimum    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Award vesting percentage   50.00%
Performance-Based | Sterling | Maximum    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Award vesting percentage   100.00%
Stock Options Outstanding    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Options outstanding, at beginning of period, Number of Shares   107,612
Options, Granted (in shares)   0
Options, Sterling replacement awards (in shares)   10,972
Options, Adjustments (in shares)   0
Options, Vested (in shares)   0
Options, Forfeited (in shares)   0
Options, Exercised (in shares)   (30,355)
Options outstanding, at end of period, Number of Shares   88,229
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Options, at beginning of period, Weighted-average Exercise Price (in dollars per share)   $ 23.05
Options, Granted (in dollars per share)   0
Options, Sterling replacement awards (in dollars per share)   29.14
Options, Adjustment (in dollars per share)   0
Options, Vested (in dollars per share)   0
Options, Forfeited (in dollars per share)   0
Options, Exercised (in dollars per share)   23.18
Options, at end of period, Weighted-average Exercise Price (in dollars per share)   $ 23.76